Society for General Microbiology. University of Bath)Symposium(63rd :2004 :
Microbe-vector interactions in vector-borne diseases : Sixty-third Symposium of the Society for General Microbiology held at the University of Bath March 2004 /
edited by S.H. Gillespie, G.L. Smith and A. Osbourn.
- Cambridge : Cambridge University Press, 2004.
- 1 online resource (ix, 383 pages) : digital, PDF file(s).
- Society for General Microbiology. Symposia ; 63 .
- Symposium of the Society for General Microbiology ; 63. .
Title from publisher's bibliographic system (viewed on 05 Oct 2015).
Vector-borne diseases / Evolution of tick-borne disease systems / Insect transmission of viruses / RNA-based immunity in insects / Specificity of Borrelia-tick vector relationships / Bunyavirus/mosquito interactions / How do mosquito vectors live with their viruses? / Vector competence / Environmental influences on arbovirus infections and vectors / Vector immunity / Transmission of plant viruses by nematodes / Wolbachia host-symbiont interactions / Pathogenic strategies of Anaplasma phagocytophilum, a unique bacterium that colonizes neutrophils / Interactions of Yersinia pesties with its flea vector that lead to the transmission of plague / Transgenic malaria / Vaccines targeting vectors B.W.J. Mahy -- S.E. Randolph -- S. Blanc -- R. Lu [and others] -- A. Barbour -- R.M. Elliott and A. Kohl -- S. Higgs -- S.C. Weaver [and others] -- P.S. Mellor -- N.A. Ratcliffe and M.M.A. Whitten -- S.A. MacFarlane and D.J. Robinson -- M.J. Taylor -- J.A. Carlyon and E. Fikrig -- B.J. Hinnebusch -- P.W. Atkinson and D.A. O'Brochta -- G.A.T. Targett.
Several billion people are at daily risk of life threatening vector-borne diseases such as malaria, trypanosomiasis and dengue. This volume describes the way in which the causal pathogens of such diseases interact with the vectors that transmit them. It details the elegant biological adaptations that have enabled pathogens to live with their vectors and, in some circumstances, to control them. This knowledge has led to novel preventative strategies in the form of antibiotics and new vaccines which are targeted not at the pathogen itself but at its specific vector.